Ibrahim Aboshady

Senior Research Scientist
The University of Texas Health Science Center at Houston, McGovern Medical School, Gulf States Hemophilia and Thrombophilia Center

Presentation(s):

• PB0167 - Emicizumab use in Acquired von Willebrand Disease: Single Case Report

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0705 - East Texas Bleeding Disorder – A Novel Bleeding Disorder

  Monday, July 11, 2022
  6:30 PM – 7:30 PM